Importance of pyrazole moiety in the field of cancer

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 2, 2012, Pages 98-104

  Pal, Dilipkumar ^a   Saha, Supriyo ^b   Singh, Shefali ^b  

^a GURU GHASIDAS UNIVERSITY   (India)

^b Himalayan Institute of Pharmacy and Research   (India)

Author keywords

A549; Antiproliferative Activity; Cancer; Cytotoxic activity; Pyrazole

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOXYLIC ACID DERIVATIVE; CHALCONE; GLYCOSIDE; HYDRAZIDE DERIVATIVE; HYDRAZONE DERIVATIVE; ISOXAZOLE DERIVATIVE; OXIME DERIVATIVE; PYRAZINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINOXALINE DERIVATIVE; TRIAZINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NEOPLASM; NONHUMAN; PAW EDEMA; REVIEW; STRUCTURE ANALYSIS;

EID: 84859941692     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. H:\nw2\Pyrazole -Wikipedia, the free encyclopedia htm.
2. Chauhana A, Sharma PK, Kaushik N, Kumar N. Synthesis Of Novel Pyrazole Analogues As Efficacious Antimicrobial Agents. Int J Pharm Pharm Sci 2011; 3 Suppl 5: 166-76.
3. Kasabe AJ, Kasabe PJ. Synthesis, anti tubercular and analgesic activity evaluation of new 3pyrazoline Derivatives. Int J Pharm Pharm sci 2010; 2 Suppl 2: 132-35.
4. Malhotra P, Pattan S, Nikalje AP. Microwave assisted synthesis and anti-inflammatory Activity of 3, 5diaryl Substituted -2pyrazolines. Int J Pharm Pharm sci 2010; 2(2): 21-26.
5. Bu X, Chen J, Deady WL, Denny WA. Synthesis and cytotoxicity of Potential anticancer derivatives of pyrazolo[3,4,5-Kl] acridine and indolo [2,3-a] acridine. Tetrahedron 2002; 58: 175-81.
6. Ohki H, Hirotani K, Naito H, Ohsuki S, Minami M, Ejima A et al. Synthesis and Mechanism of Action of Novel Pyrimidinyl Pyrazole Derivatives Possessing Antiproliferative Activity. Bioorg Med Chem Lett 2002; 12: 3191-93.
7. Wei F, Zhao BX, Huang B, Zhang L, Sun CH, Dong WL et al. Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(20-hydroxy-30-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate. Bioorg Med Chem Lett 2006; 16: 6342-47.
8. Xia Y, Dong ZW, Zhao BX, Ge X, Meng N, Shin DS et al. Synthesis and structure-activity relationships of novel 1-arylmethyl-3- aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer. Bioorg Med Chem 2007;15: 6893-99.
9. Fan CD, Zhao BX, Wei F, Zhang GH, Dong WL, Miao JY. Synthesis and discovery of autophagy inducers for A549 and H460 lung cancer cells, novel 1-(20-hydroxy-30-aroxypropyl)-3-aryl-1Hpyrazole- 5-carbohydrazide derivatives. Bioorg Med Chem Lett 2008; 18: 3860-64.
10. Xie YS, Pan XH, Zhao BX, Liu JT, Shin DS, Zhang JH et al. Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7- dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives. J Organometal Chem 2008; 693: 1367-74.
11. Zhang JH, Fan CD, Zhao BX, Shin DS, Dong WL, Xie YS et al. Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a] pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells. Bioorg Med Chem 2008; 16: 10165-171.
12. Ding XL, Zhang HY, Qi L, Zhao BX, Lian S, Lv HS et al. Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells. Bioorg Med Chem Lett 2009; 19: 5325-328.
13. Zheng LW, Wu LL, Zhao BX, Dong WL, Miao JY. Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Bioorg Med Chem 2009; 17: 1957-962.
14. Lian S, Su H, Zhao BX, Liu WY, Zheng LW, Miao JY. Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells. Bioorg Med Chem 2009; 17: 7085-092.
15. Zheng LW, Li Y, Geb D, Zhao BX, Liu YR, Lv HS et al. Synthesis of novel oxime containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells. Bioorg Med Chem Lett. 2010; 20: 4766-770.
16. Fan CD, Su H, Zhao J, Zhao BX, Zhang SL, Miao JY. A novel copper complex of salicylaldehyde pyrazole hydrazone induces apoptosis through up-regulating integrin b4 in H322 lung carcinoma cells. Eur J Med Chem 2010; 45: 1438-446.
17. Zheng LW, Zhu J, Zhao BX, Huang YH, Ding J, Miao JY. Synthesis, crystal structure and biological evaluation of novel 2-(5- (hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives. Eur J Med Chem 2010; 45:5792-799.
18. Zheng LW, Shao JH, Zhao BX, Miao JY. Synthesis of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives and their inhibition against growth of A549 and H322 lung cancer cells. Bioorg Med Chem Lett 2011; 21: 3909-913.
19. Balbi A, Anzaldi M, Maccio C, Aiello C, Mazzei M, Gangemi R et al. Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity. Eur J Med Chem 2011; 46: 5293-309.
20. Quirante J, Ruiz D, Gonzalez A, Lopez C, Cascante M, Cortes R et al. Platinum(II) and palladium(II) complexes with (N,N) and (C,N,N)- ligands derived from pyrazole as anticancer and antimalarial agents: Synthesis, characterization and in vitro activities. J Inorg Biochem 2011; 105: 1720-728.
21. Chou LC, Huang LJ, Hsu MH, Fang MC, Yang JS, Zhuang SH et al. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2- c]pyrazole derivatives as new anticancer agents. Eur J Med Chem 2010; 45: 1395-1402.
22. Ghorab MM, Ragab FA, Alqasoumi SI, Alafeefy AM, Aboulmagd SA. Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity. Eur J Med Chem 2010; 45: 171-78.
23. Joksovic MD, Markovic V, Juranic ZD, Stanojkovic T, Jovanovic LS, Damljanovic IS et al. Synthesis, characterization and antitumor activity of novel N-substituted a-amino acids containing ferrocenyl pyrazole-moiety. J Organometal Chem 2009; 694: 3935-42.
24. Abu-Surrah AS, Abu Safieh KA, Ahmad IM, Abdalla MY, Ayoub MT, Qaroush AK et al. New palladium(II) complexes bearing pyrazole-based Schiff base ligands: Synthesis, characterization and cytotoxicity. Eur J Med Chem 2010; 45: 471-75.
25. Lv PC, Li HQ, Sun J, Zhou Y, Zhu HL. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg Med Chem 2010; 18: 4606-614.
26. Hassan GS, Kadry HH, Abou-Seri SM, Ali MM, Mahmoud AEED. Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4- d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line. Bioorg Med Chem 2011;19: 6808-817.
27. Lv HS, Kong XQ, Ming QQ, Jin X, Miao JY, Zhao BX. Synthesis of 5-benzyl-2-phenylpyrazolo[1,5-a]pyrazin-4,6(5H,7H)-dione derivatives and discovery of an apoptosis inducer for H322 lung cancer cells. Bioorg Med Chem Lett 2011; 1-24.
28. LeBlanc R, Dickson J, Brown T, Stewart M, Pati HN, Derveer DV et al. Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins. Bioorg Med Chem 2005; 13: 6025-34.
29. Tan JH, Zhang QX, Huang ZS, Chen Y, Wang XD, Gu LQ et al. Synthesis, DNA binding and cytotoxicity of new pyrazole emodin derivatives. Eur J Med Chemistry 2006; 41: 1041-47.
30. Hasinoff BB, Liang H, Wu X, Guziec LJ, Guziec FS et al. The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds. Bioorg Med Chem 2008; 16: 3959-968.
31. Nagarapu L, Gaikwad HK, Sarikonda K, Mateti J, Bantu R, Raghu PS et al. Synthesis and cytotoxicity evaluation of 1-[3-(9Hcarbazol- 4-yloxy)-2-hydroxypropyl]-3-aryl-1H-pyrazole-5- carboxylic acid derivatives. Eur J Med Chem 2010; 45: 4720-725.
32. Zhang D, Wang G, Zhao G, Xu W, Huo L. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5- carbohydrazide derivatives. Eur J Med Chem 2011; 46: 5868-877.
33. Santos MSD, Oliveira MLV, Bernardino AMR, Leo RMD, Amaral VF, Carvalho FTD et al. Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1Hpyrazole derivatives. Bioorg Med Chem Lett 2011; 21: 7451-54.
34. Farag AM, Ali KAK, El-Debss TMA, Mayhoub AS, Amr AGE, Abdel-Hafez NA et al. Design, synthesis and structureeactivity relationship study of novel pyrazole-based heterocycles as potential antitumor agents. Eur J Med Chem 2010; 45: 5887-898.
35. El-Deeb IM, Lee SH. Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity. Bioorg Med Chem 2010; 18: 3961-973.
36. Das J, Pany S, Panchal S, Majhi A, Rahman GM. Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C. Bioorg Med Chem 2011;19: 6196-202.
37. Menozzi G, Merello L, Fossa P, Mosti L, Piana A, Mattioli F. 4- Substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties. IL Farmaco 2003; 58: 795-808.
38. Bekhit AA, Aziem TA. Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Medi Chem 2004; 12: 1935-45.
39. Manna F, Chimenti F, Fioravanti R, Bolasco A, Secci D, Chimenti P et al. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein. Bioorg Medi Chem Lett 2005; 15: 4632-35.
40. Tandon VK, Yadav DB, Chaturvedi AK, Shukla PK. Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)- naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents. Bioorg Med Chem Lett 2005; 15: 3288-91.
41. Burguete A, Pontiki E, Litina DH, Villar R, Vicente E, Solano B et al. Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5- dihydro-(1H)-pyrazole analogues. Bioorg Med Chem Lett 2007;17: 6439-43.
42. Via LD, Marini AM, Salerno S, Motta CL, Condello M, Arancia G et al. Synthesis and biological activity of 1,4- dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel proapoptotic mitochondrial targeted agents. Bioorg Med Chem 2009; 17: 326-36.
43. Ciciani G, Coronnello M, Guerrini G, Selleri S, Cantore M, Failli P et al. Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions. Bioorg Med Chem 2008; 16: 9409-19.
44. Das J, Pany S, Panchal S, Majhi A, Rahman GM. Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C. Bioorg Med Chem 2011; 19: 6196-202.
45. Feher C, Kuik A, Mark L, Kollar L, Foldes RS. A two-step synthesis of ferrocenyl pyrazole and pyrimidine derivatives based on carbonylative Sonogashira coupling of iodoferrocene. J Organometal Chem 2009; 694: 4036-041.
46. Bandgar BP, Totre JV, Gawande SS, Khobragade CN, Warangkar SC, Kadam PD. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, antiinflammatory agents. Bioorg Med Chem 2010; 18: 6149-155.
47. Nitulescu GM, Draghici C, Missir AV. Synthesis of new pyrazole derivatives and their anticancer evaluation. Eur J Med Chem 2010; 45: 4914-919.
48. Insuasty B, Tigreros A, Orozco F, Quiroga J, Abonia R, Nogueras M et al. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg Med Chem 2010; 18: 4965-974.